Short-Read Next-Generation DNA Sequencing System

Closed Solicitation Posted

Solicitation number
NIAID-SS-24-2225904
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Bethesda, Maryland, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Health and Human Services' National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), is seeking to acquire a highly accurate, next-generation DNA sequencing instrument. The objective is to enhance the Quantitative Virology and Evolution Unit's capacity for rare variant discovery and improved sensitivity. The key requirements include 90% accuracy at a quality score of Q40, compatibility with existing Illumina libraries, and the ability to detect variants down to 0.001%. The acquisition will be evaluated based on the vendor's capability to meet the technical requirements and price, with a firm fixed-price purchase order award anticipated. Quotations are due by September 18, 2024.

This procurement is not set aside for small businesses under NAICS code 334516, Analytical Laboratory Instrument Manufacturing. The government anticipates making a single award, but does not provide any details on potential incumbents, award values, or budget ranges. The place of performance is Bethesda, MD, and the period of performance is estimated from September 27, 2024 through December 26, 2024, with delivery required within 90 days of award.

Notice text

See attached Request for Quote (RFQ) for more information.

Files

File Type Posted
RFQ_AMBIS 2225904 Amendment 1.pdf PDF
RFQ_AMBIS 2225904 Final.pdf PDF

Notice history

Notice Type Posted
This notice Latest solicitation Solicitation
Short-Read Next-Generation DNA Sequencing System Original Pre-Solicitation

Similar open opportunities

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity